GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » 5-Year Yield-on-Cost %

Sinopharm Tech Holdings (HKSE:08156) 5-Year Yield-on-Cost % : 0.00 (As of May. 03, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings 5-Year Yield-on-Cost %?

Sinopharm Tech Holdings's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for Sinopharm Tech Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:



HKSE:08156's 5-Year Yield-on-Cost % is not ranked *
in the Software industry.
Industry Median: 2.415
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Sinopharm Tech Holdings's 5-Year Yield-on-Cost %

For the Software - Application subindustry, Sinopharm Tech Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Tech Holdings's 5-Year Yield-on-Cost % Distribution in the Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's 5-Year Yield-on-Cost % falls into.


;
;

Sinopharm Tech Holdings 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Sinopharm Tech Holdings is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Sinopharm Tech Holdings  (HKSE:08156) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Sinopharm Tech Holdings 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Tech Holdings Business Description

Traded in Other Exchanges
N/A
Address
Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18th Floor, Ruttonjee House, Hong Kong Central, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Internet Plus services; Supply chain services; and Manufacturing and distribution of personal protective equipment. It generates maximum revenue from Supply chain services segment, which includes provision of supply chain management, data analysis and related services and trading of related goods, and trading of medial and related products. Geographically, it derives a majority of revenue from Hong Kong.
Executives
Chiu Sin Nang Kenny 2201 Interest of corporation controlled by you
Creative Big Limited 2101 Beneficial owner
Integrated Asset Management (asia) Limited 2101 Beneficial owner
Yam Tak Cheung 2201 Interest of corporation controlled by you
Quantum Worldwide Investment Limited 2101 Beneficial owner
Best Frontier Investments Limited
Chan Kin Ho Philip 2201 Interest of corporation controlled by you
Lam Yui Keung 2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited 2101 Beneficial owner
Main Key Investments Limited 2201 Interest of corporation controlled by you
Guo Lei 2201 Interest of corporation controlled by you
Chan Tung Mei 2202 Interest of your spouse
Cheung Kwai Lan 2201 Interest of corporation controlled by you
Tse Siu Hoi 2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.) 2102 Investment manager

Sinopharm Tech Holdings Headlines

No Headlines